Astera Labs Initiated at Outperform with $225 Price Target by BNP Paribas Exane

Astera Labs has been initiated with an 'Outperform' rating by BNP Paribas Exane. Additionally, BNP Paribas Exane has set a price target of $225.00 per share for Astera Labs. This indicates a positive outlook on the company's stock performance.

Latest News

11-20
Astera Labs Initiated at Outperform by BNP Paribas Exane
Astera Labs Initiated at Outperform by BNP Paribas Exane
11-20
BNP Paribas Exane Initiates Coverage on Astera Labs With Outperform Rating, $225 Price Target
BNP Paribas Exane Initiates Coverage on Astera Labs With Outperform Rating, $225 Price Target
11-20
Astera Labs initiated with an Outperform at BNP Paribas Exane
Astera Labs initiated with an Outperform at BNP Paribas Exane

User Discussion

Where is the support line for astera 
BNP Paribas Exane Initiates Coverage on Astera Labs With Outperform Rating, $225 Price Target